Jolly Douglas 4
4 · Tocagen Inc · Filed May 29, 2019
Insider Transaction Report
Form 4
Tocagen IncTOCA
Jolly Douglas
EVP, Research & Pharm Devel
Transactions
- Award
Common Stock
2018-12-10$8.19/sh+732$5,995→ 393,478 total - Award
Common Stock
2018-06-08$8.19/sh+703$5,758→ 392,746 total
Holdings
- 21,739(indirect: By daughter)
Common Stock
- 21,739(indirect: By son)
Common Stock
Footnotes (3)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 703 shares by the Reporting Person on June 8, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]This Form 4 is being filed voluntarily to report the acquisition of 732 shares by the Reporting Person on December 10, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.